Prime Time for Genome Editing? Urnov Fyodor D et al. The New England journal of medicine 2020 01 (5) 481-484

Hot Topics of the Day|PHGKB


Last Posted: Jan 31, 2020

---

• Prime Time for Genome Editing?
  Urnov Fyodor D et al. The New England journal of medicine 2020 01 (5) 481-484
• Genome Editing for Mucopolysaccharidoses.
  Poletto Edina et al. International journal of molecular sciences 2020 Jan 21(2)
• Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
  Li Hongyi et al. Signal transduction and targeted therapy 2020 1
• Beyond Mendelian Genetics: Anticipatory Biomedical Ethics and Policy Implications for the Use of CRISPR Together with Gene Drive in Humans.
  Nestor Michael W et al. Journal of bioethical inquiry 2020 Jan
• Navigating 2020 and beyond
  Nature Genetics editorial, January 7, 2020
• Quest to use CRISPR against disease gains ground
  H Ledford, Nature, January 6, 2020
• Gene Therapies Make It to Clinical Trials
  L Marsa, Discover, December 2020
• Gene editing prospects for treating inherited retinal diseases.
  Benati Daniela et al. Journal of medical genetics 2019 Dec
• Safety of Germline Genome Editing for Genetically Related "Future" Children as Perceived by Parents.
  Ishii Tetsuya et al. The CRISPR journal 2019 Nov
• Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa.
  Diakatou Michalitsa et al. International journal of molecular sciences 2019 May 20(10)

more